4-Benzamido-benzoylchlorid | 137976-39-7

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 4-Benzamido-benzoylchlorid
• 英文别名: 4-benzoylaminobenzoyl chloride；4-benzamidobenzoyl chloride
• CAS: 137976-39-7
• 化学式: C₁₄H₁₀ClNO₂
• 分子量: 259.692
• InChiKey: NIWOKLSYURSHMT-UHFFFAOYSA-N

物化性质

• 沸点：
  323.3±25.0 °C(Predicted)
• 密度：
  1.333±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3.1
• 重原子数：
  18
• 可旋转键数：
  3
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  46.2
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  4-Benzamido-benzoylchlorid 在 一水合肼 、 溶剂黄146 、 sodium hydroxide 作用下， 以 甲醇 为溶剂， 反应 2.0h， 生成 4-(4-(1-(2-(4-benzamidobenzoyl)hydrazono)ethyl)phenylsulfonamido)benzoic acid
  参考文献：
  名称：

  Design and Bioevaluation of Novel Hydrazide-Hydrazones Derived from 4-Acetyl-N-Substituted Benzenesulfonamide

  摘要：

  In this research, a series of hydrazine-hydrazone derivatives (Ia-g), (IIa-h) were synthesized to discover new antioxidant and anticholinesterase agents. The structures of synthesized compounds were characterized by spectroscopic data using UV, IR, H-1, C-13 NMR, mass spectroscopy, and elemental analysis. The bio-evaluation of the synthesized compounds (Ia-g), (IIa-h) were evaluated according to in vitro activity assays. The results of beta-carotene/linoleic acid assay showed that among the synthesized compounds, the (Ib), (Ie), (IIb-IIe), and (IIh) compound exhibited higher activity for the lipid peroxidation inhibitory activity. In the DPPH free scavenging activity and the cation radical scavenging activity in ABTS(center dot+) activity, compound (IIb) was found to be more active. In the CUPRAC reduced power assay, the A(0.5) values of all synthesized compounds were better than alpha-TOC. In AChE assay, compound (IIb) exhibited the most activity with IC50 = 11.12 +/- 0.74 mu M, while the compounds (Ib-g) and (IIb-h), exhibited excellent activity than the positive standard galantamine (IC50 = 46.06 +/- 0.10 mu M) in the BChE assay.

  DOI：

  10.1134/s1068162020050052
• 作为产物：
  描述：

  4-(苯甲酰基氨基)苯甲酸 在 氯化亚砜 作用下， 以 甲苯 为溶剂， 生成 4-Benzamido-benzoylchlorid
  参考文献：
  名称：

  Synthesis of p-aminobenzoic acid diamides based on 4-(4-methoxyphenyl)tetrahydro-2H-pyran-4-carboxylic acid and [4-(4-methoxyphenyl)tetrahydro-2H-pyran-4-yl]methylamine

  摘要：

  Reaction of 4-(4-methoxyphenyl)tetrahydro-2H-pyran-4-carboxyl chloride with anesthesin followed by hydrolysis of the formed ester has afforded 4-[4-(4-methoxyphenyl)tetrahydro-2H-pyran-4-carbonylamino]benzoic acid. The acid chloride has been used for acylation of various amines to yield the corresponding diamides. Reaction of [4-(4-methoxyphenyl)tetrahydro-2H-pyran-4-yl]methylamine with chlorides of N-substituted p-aminobenzoic acids has led to formation of diamides.

  DOI：

  10.1134/s1070363215050096

文献信息

• Benzoheterocyclic compounds
  申请人：Otsuka Pharmaceutical Co., Ltd.

  公开号：US05559230A1

  公开（公告）日：1996-09-24

  Novel benzoheterocyclic compounds of the formula: ##STR1## wherein R.sup.1 is H, halogen, alkyl, optionally substituted amino, alkoxy; R.sup.2 is H, halogen, alkoxy, phenyialkoxy, OH, alkyl, optionally substituted amino, carbamoyl-alkoxy, optionally substituted amino-alkoxy, optionally substituted benzoyloxy; R.sup.3 is a group: --NR.sup.4 R.sup.5 or --CO--NR.sup.11 R.sup.12 ; R.sup.4 is H, optionally substituted benzoyl, alkyl; R.sup.5 is a group: ##STR2## [R.sup.16 is halogen, optionally substituted alkyl, OH, alkoxy, alkanoyloxy, alkylthio, alkanoyl, carboxy, alkoxycarbonyl, CN, NO.sub.2, optionally substituted amino, phenyl, cycloalkyl, etc., or a group: --O--A--NR.sup.6 R.sup.7 ; m is 0 to 3], phenyl-alkoxycarbonyl, alkanoyl, phenylalkanoyl, etc.; R.sup.11 is H or alkyl; R.sup.12 is cycloalkyl or optionally substituted phenyl; and W is a group: --(CH.sub.2).sub.p (p is 3 to 5) or --CH.dbd.CH--(CH.sub.2).sub.q (q is 1 to 3), the carbon atom of these groups being optionally replaced by O, S, SO, SO.sub.2 or a group: --N(R).sup.12 and further these groups having optionally 1 to 3 substituents of alkyl, alkoxycarbonyl, carboxy, OH, O, alkanoyloxy, etc., which have excellent vasopressin antagonistic activities and are useful as vasodilator, hypotensive agent, water diuretics, platelet agglutination inhibitor, and a vasopressin antagonistic composition containing the compound as the active ingredient.

  新型苯杂环化合物的化学式为：##STR1## 其中R.sup.1为H、卤素、烷基、可选择取代的氨基、烷氧基；R.sup.2为H、卤素、烷氧基、苯基烷氧基、羟基、烷基、可选择取代的氨基、氨基羰基烷氧基、可选择取代的氨基烷氧基、可选择取代的苯甲酰氧基；R.sup.3为一基团：--NR.sup.4 R.sup.5 或 --CO--NR.sup.11 R.sup.12 ；R.sup.4为H、可选择取代的苯甲酰、烷基；R.sup.5为一个基团：##STR2## [R.sup.16为卤素、可选择取代的烷基、羟基、烷氧基、烷酰氧基、烷硫基、烷酰基、羧基、烷氧羰基、氰基、硝基、可选择取代的氨基、苯基、环烷基等，或一个基团：--O--A--NR.sup.6 R.sup.7 ；m为0至3]、苯基-烷氧羰基、烷酰基、苯基烷酰基等；R.sup.11为H或烷基；R.sup.12为环烷基或可选择取代的苯基；W为一个基团：--(CH.sub.2).sub.p (p为3至5) 或 --CH.dbd.CH--(CH.sub.2).sub.q (q为1至3)，这些基团的碳原子可选择被O、S、SO、SO.sub.2 或一个基团：--N(R).sup.12 取代，而这些基团进一步可选择具有1至3个烷基、烷氧羰基、羧基、羟基、O、烷酰氧基等取代基，具有出色的抗利尿激素活性，可用作血管扩张剂、降压剂、利尿剂、血小板凝集抑制剂，以及含有该化合物作为活性成分的抗利尿激素拮抗剂组合物。
• [EN] BENZOHETEROCYCLIC COMPOUNDS
  申请人：OTSUKA PHARMACEUTICAL CO., LTD.

  公开号：WO1991005549A1

  公开（公告）日：1991-05-02

  (EN) Novel benzoheterocyclic compounds of formula (I), wherein R1 is H, halogen, alkyl, optionally substituted amino, alkoxy; R2 is H, halogen, alkoxy, phenylalkoxy, OH, alkyl, optionally substituted amino, carbamoyl-alkoxy, optionally substituted amino-alkoxy, optionally substituted benzoyloxy; R3 is a group: -NR4R5 or -CO-NR11R12; R4 is H, optionally substituted benzoyl, alkyl; R5 is a group $g(a) [R16 is halogen, optionally substituted alkyl, OH, alkoxy, alkanoyloxy, alkylthio, alkanoyl, carboxy, alkoxycarbonyl, CN, NO2, optionally substituted amino, phenyl, cycloalkyl, etc., or a group: -O-A-NR6R7; m is 0 to 3], phenyl-alkoxycarbonyl, alkanoyl, phenyl-alkanoyl, etc.; R11 is H or alkyl; R12 is cycloalkyl or optionally substituted phenyl; and W is a group: -(CH2)p (p is 3 to 5) or -CH=CH-(CH2)q (q is 1 to 3), the carbon atom of these groups being optionally replaced by 0, S, SO, SO2 or a group: -N(R13)- and further these groups having optionally 1 to 3 substituents of alkyl, alkoxycarbonyl, carboxy, OH, O, alkanoyloxy, etc., which have excellent vasopressin antagonistic activies and are useful as vasodilator, hypotensive agent, water diuretics, platelet agglutination inhibitor, and a vasopressin antagonistic composition containing the compound as the active ingredient.(FR) Nouveaux composés benzohétérocycliques de formule (I), dans laquelle R1 représente H, halogène, alkyle, amino éventuellement substitué, alcoxy; R2 représente H, halogène, alcoxy, phénylalcoxy, OH, alkyle, amino éventuellement substitué, carbamoyle-alcoxy, amino-alcoxy éventuellement substitué, benzoyloxy éventuellement substitué; R3 représente un groupe -NR4R5 ou -CO-NR11R12; R4 est H, benzoyle éventuellement substitué, alkyle; R5 est un groupe $g(a) [dans lequel R16 représente halogène, alkyle éventuellement substitué, OH, alcoxy, alcanoyloxy, alkylthio, alcanoyle, carboxy, alcoxycarbonyle, CN, NO2, amino éventuellement substitué, phényle, cycloalkyle, etc., ou un groupe -O-A-NR6R7; m est compris entre 0 et 3], phényl-alcoxycarbonyle, alcanoyle, phényl-alcanoyle, etc.; R11 représente H ou alkyle; R12 représente cycloalkyle ou phényle éventuellement substitué; et W est un groupe -CH2)p (p étant compris entre 3 et 5) ou -CH=CH-(CH2)q (q étant compris entre 1 et 3), l'atome de carbone de ces groupes étant éventuellement remplacé par 0, S, SO, SO2 ou un groupe -N(R13)-, ces groupes comportant éventuellement de 1 à 3 substituants d'alkyle, alcoxycarbonyle, carboxy, OH, O, alcanoyloxy, etc. Ces composés présentent d'excellentes activités antagonistes de la vasopressine et sont utiles en tant que vasodilateurs, agents hypotensifs, diurétiques et inhibiteurs d'agglutination de plaquettes. On décrit également une composition antagoniste de la vasopressine contenant ce composé en tant qu'ingrédient actif.

  新的苯并杂环化合物，其化学式为（I），其中R1为H，卤素，烷基，可选择取代的氨基，烷氧基；R2为H，卤素，烷氧基，苯基烷氧基，OH，烷基，可选择取代的氨基，氨基-卡巴莫基烷氧基，可选择取代的氨基-烷氧基，可选择取代的苯甲酰氧基；R3为一个基团：-NR4R5或-CO-NR11R12；R4为H，可选择取代的苯甲酰基，烷基；R5为一个基团$g(a) [其中R16为卤素，可选择取代的烷基，OH，烷氧基，烷酰氧基，烷硫基，烷酰基，羧基，烷氧羰基，CN，NO2，可选择取代的氨基，苯基，环烷基等，或一个基团：-O-A-NR6R7；m为0至3]，苯基-烷氧羰基，烷酰基，苯基-烷酰基等；R11为H或烷基；R12为环烷基或可选择取代的苯基；W为一个基团：-(CH2)p（p为3至5）或-CH=CH-(CH2)q（q为1至3），这些基团的碳原子可以选择性地被0，S，SO，SO2或一个基团：-N（R13）-替换，并且这些基团还可以具有1至3个取代基，如烷基，烷氧羰基，羧基，OH，O，烷酰氧基等，具有出色的抗利尿激素拮抗活性，并且可用作扩血管剂，降压剂，利尿剂，血小板凝聚抑制剂和含有该化合物的抗利尿激素拮抗剂组合物的活性成分。
• Julia,M.; Gombert,R., Bulletin de la Societe Chimique de France, 1968, p. 376 - 382
  作者：Julia,M.、Gombert,R.

  DOI：——

  日期：——
• Synthesis and evaluation of spirobenzazepines as potent vasopressin receptor antagonists
  作者：Min Amy Xiang、Robert H. Chen、Keith T. Demarest、Joseph Gunnet、Richard Look、William Hageman、William V. Murray、Donald W. Combs、Mona Patel

  DOI：10.1016/j.bmcl.2004.02.103

  日期：2004.6

  A novel series of spirobenzazepines was synthesized and evaluated for V-1a and V-2 receptor antagonist activity. Compounds 8b, 8i, and 8k have shown selective V-1a receptor antagonist activity. Compounds 8p and 8q were shown to be dual V-1a/V-2 receptor antagonists. (C) 2004 Elsevier Ltd. All rights reserved.
• BENZOHETEROCYCLIC COMPOUNDS
  申请人：OTSUKA PHARMACEUTICAL CO., LTD.

  公开号：EP0450097B1

  公开（公告）日：1996-04-24